Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury

Pharmacogenetics and Genomics

Volumn 25, Issue 10, 2015, Pages 485-490

  Dardiotis, Efthimios ^a   Paterakis, Konstantinos ^a   Siokas, Vasileios ^a   Tsivgoulis, Georgios ^d,g   Dardioti, Maria ^a   Grigoriadis, Savas ^e   Simeonidou, Constantina ^f   Komnos, Apostolos ^b   Kapsalaki, Eftychia ^c   Fountas, Kostas ^a   Hadjigeorgiou, Georgios M ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b GENERAL HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e Hippokration University Hospital   (Greece)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

angiotensin converting enzyme; polymorphism; tag single nucleotide polymorphisms; traumatic brain injury

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ACE PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CODOMINANCE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLASGOW OUTCOME SCALE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TRAUMATIC BRAIN INJURY; ADOLESCENT; ALLELE; BRAIN INJURY; DEMOGRAPHY; GENE LOCUS; GENETICS; GLASGOW COMA SCALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRAIN INJURIES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC LOCI; GLASGOW COMA SCALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941953373     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0000000000000161     Document Type: Article

References (28)

1. Selassie AW, Zaloshnja E, Langlois JA, Miller T, Jones P, Steiner C. Incidence of long-Term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil 2008; 23:123-131.
2. Dardiotis E, Fountas KN, Dardioti M, Xiromerisiou G, Kapsalaki E, Tasiou A, Hadjigeorgiou GM. Genetic association studies in patients with traumatic brain injury. Neurosurg Focus 2010; 28:E9.
3. Dardiotis E, Grigoriadis S, Hadjigeorgiou GM. Genetic factors influencing outcome from neurotrauma. Curr Opin Psychiatry 2012; 25:231-238.
4. Graham DI, McIntosh TK, Maxwell WL, Nicoll JA. Recent advances in neurotrauma. J Neuropathol Exp Neurol 2000; 59:641-651.
5. Démolis P, Carville C, Giudicelli JF. Effects of an angiotensin-converting enzyme inhibitor, lisinopril, on cerebral blood flow autoregulation in healthy volunteers. J Cardiovasc Pharmacol 1993; 22:373-380.
6. Oba R, Igarashi A, Kamata M, Nagata K, Takano S, Nakagawa H. The N-Terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. Eur J Neurosci 2005; 21:733-740.
7. Yokosawa H, Endo S, Ogura Y, Ishii S. A new feature of angiotensinconverting enzyme in the brain: hydrolysis of substance P. Biochem Biophys Res Commun 1983; 116:735-742.
8. Ariza M, Matarin MD, Junqué C, Mataró M, Clemente I, Moral P, et al. Influence of angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury. J Neuropsychiatry Clin Neurosci 2006; 18:39-44.
9. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98:1123-1133.
10. Hadjigeorgiou GM, Paterakis K, Dardiotis E, Dardioti M, Aggelakis K, Tasiou A, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology 2005; 65:1077-1082.
11. Dardiotis E, Dardioti M, Hadjigeorgiou GM, Paterakis K. Re: Lack of association between the IL1A gene (? 889) polymorphism and outcome after head injury. Tanriverdi T et al. Surg Neurol 2006; 65:7-10; discussion 10. Surg Neurol 2006; 66:334-335.
12. Dardiotis E, Paterakis K, Tsivgoulis G, Tsintou M, Hadjigeorgiou GF, Dardioti M, et al. AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. J Neurotrauma 2014; 31:1920-1926.
13. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350:1069-1071.
14. Dardiotis E, Jagiella J, Xiromerisiou G, Dardioti M, Vogiatzi C, Urbanik A, et al. Angiotensin-converting enzyme tag single nucleotide polymorphisms in patients with intracerebral hemorrhage. Pharmacogenet Genomics 2011; 21:136-141.
15. Carter KW, McCaskie PA, Palmer LJ. SimHap GUI: An intuitive graphical user interface for genetic association analysis. BMC Bioinformatics 2008; 9:557.
16. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligationcombination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009; 19:519-523.
17. Carter KW, McCaskie PA, Palmer LJ. JLIN: A java based linkage disequilibrium plotter. BMC Bioinformatics 2006; 7:60.
18. Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 2007; 31:358-362.
19. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: A web tool for the analysis of association studies. Bioinformatics 2006; 22:1928-1929.
20. Maas AI, Lingsma HF, Roozenbeek B. Predicting outcome after traumatic brain injury. Handb Clin Neurol 2015; 128:455-474.
21. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, et al. Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 2000; 67:1144-1153.
22. Friedman A, Bar-Klein G, Serlin Y, Parmet Y, Heinemann U, Kaufer D. Should losartan be administered following brain injury? Expert Rev Neurother 2014; 14:1365-1375.
23. Baranov D, Armstead WM. Selective blockade of AT1 receptor attenuates impairment of hypotensive autoregulation and improves cerebral blood flow after brain injury in the newborn pig. Anesthesiology 2003; 99:1118-1124.
24. Timaru-Kast R, Wyschkon S, Luh C, Schaible EV, Lehmann F, Merk P, et al. Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma. Crit Care Med 2012; 40:935-944.
25. Namsolleck P, Boato F, Schwengel K, Paulis L, Matho KS, Geurts N, et al. AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol Dis 2013; 51:177-191.
26. Panahpour H, Dehghani GA, Bohlooli S. Enalapril attenuates ischaemic brain oedema and protects the blood-brain barrier in rats via an antioxidant action. Clin Exp Pharmacol Physiol 2014; 41:220-226.
27. Harford-Wright E, Thornton E, Vink R. Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury. Neurosci Lett 2010; 481:26-29.
28. Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J Cereb Blood Flow Metab 2009; 29:1388-1398.